Company Filing History:
3 out of 10 
2 out of 677 
1 out of 232 
Years Active: 1991-1993
Title: Hiroyuki Fujimori: Innovator in Pharmacological Compositions
Introduction
Hiroyuki Fujimori is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of innovative compositions for medical applications. With a total of 3 patents to his name, Fujimori's work has the potential to impact patient care positively.
Latest Patents
Fujimori's latest patents include a groundbreaking formulation titled "Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone." This pharmacological composition is designed for percutaneous administration to human patients. It comprises a pharmacologically effective amount of eperisone, a salt thereof, tolperisone or a salt thereof, a water-swellable crosslinked polyvinylpyrrolidone, and a base carrier. This innovative formulation exhibits improved percutaneous absorption, enhancing the efficacy of the treatment. Another notable patent is "Preparation for endermism containing dopamine derivatives," which further showcases his expertise in pharmacological innovations.
Career Highlights
Throughout his career, Fujimori has worked with prominent companies in the pharmaceutical industry. He has been associated with Sansho Co., Ltd. and Eisai Company, Limited, where he has contributed to various research and development projects. His work in these organizations has allowed him to refine his skills and expand his knowledge in the field.
Collaborations
Fujimori has collaborated with several talented individuals in his field. Notable coworkers include Mitsuhiro Yoshida and Masayoshi Kasai, who have worked alongside him on various projects. Their combined expertise has contributed to the success of their innovations.
Conclusion
Hiroyuki Fujimori is a distinguished inventor whose work in pharmacological compositions has the potential to revolutionize patient treatment. His innovative patents and collaborations highlight his commitment to advancing medical science. His contributions will undoubtedly leave a lasting impact on the field of pharmacology.